Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

Basaglar has been approved as a "follow-on" drug based on clinical comparisons with Lantus, the first time ... undercutting the long-acting Levemir (insulin detemir) by 21% and Tresiba (insulin ...

Sanofi faces setbacks after itepekimab’s Phase 3 COPD failure, removing a key growth prospect and highlighting reliance on ...

Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is ...

Metformin, the sulphonylureas and the TZDs were the most prescribed classes of non-insulin antidiabetic medications, accounting for 96% of all prescriptions in the US. However, with metformin and ...

If you use insulin to manage diabetes, you may want to take your protein consumption into consideration when determining your mealtime doses. Protein is made up of molecules called amino acids ...